HRX 2022: GPX Inc: Novel AI Algorithmic Blood Biomarker Monitoring

HRX 22 - GPX Inc. CEO Javier Echenique (GPX Inc., Boston, MA, US) joins us to discuss CardioID - a novel AI Algorithm-based "bloodless blood test" that uses NT-proBNP biomarkers in patient

SciELO - Brasil - Early Initiation of Extracorporeal Blood

GPx (@GPx_Boston) / X

Somavedic Launches AI-Enabled, Biomarker Analysis App

PDF) Association of Vegetable and Fruit Consumption with Urinary

Sean (Shunsuke) Matsuoka på LinkedIn: HRX 2022: GPX Inc: Novel AI

Metabolites, Free Full-Text

Frontiers Use of the NIH consensus criteria in cellular and soluble biomarker research in chronic graft-versus-host disease: A systematic review

PDF) Association of Vegetable and Fruit Consumption with Urinary

先端AIのベンチャーが登場するSXSW2023のピッチファイナリスト

AAIC 2023 Poster: A novel automated multiplex immunoassay for

Study Confirming Overwhelming Reduction in Bleeding of the Dual-Acting Factor XI/XIa Inhibitor Abelacimab as Compared to Rivaroxaban Selected as Late-Breaker Oral Presentation at the American Heart Association Scientific Sessions

PDF) Automated Retinal Imaging System for Detecting Cardiac Abnormalities Using Cup to Disc Ratio